NDC 59676-040 – Balversa

Erdafitinib 4 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC59676-040

Product details

Brand name
Balversa
Generic name
Erdafitinib
Labeler
Janssen Products LP
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
NDA · NDA212018
Marketed since
April 12, 2019
Listing expires
December 31, 2026
Pharmacologic class
Kinase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Balversa →

Package NDC codes (2)

Package NDCDescriptionSince
59676-040-281 BOTTLE in 1 CARTON (59676-040-28) / 28 TABLET, FILM COATED in 1 BOTTLEApr 12, 2019
59676-040-561 BOTTLE in 1 CARTON (59676-040-56) / 56 TABLET, FILM COATED in 1 BOTTLEApr 12, 2019

Other Balversa products